Theravance Biopharma Stock Forecast
Explanation to Bollinger's Bands
Bollinger Bands was created by John Bollinger in the early 1980s, its purpose is to define price action relative to the assets highs and lows. This technical indicator is used to identify buy and sell signals and has proven very well in doing so.
Bollinger Bands consist of a set of three curves drawn in relation to securities prices. The middle band is a measure of the intermediate-term trend, usually a simple moving average, that serves as the base for the upper and lower bands. The interval between the upper and lower bands and the middle band is determined by volatility, typically the standard deviation of the same data that were used for the average. StockInvest.us uses Bollingers suggested 20 day average.
Middle Bollinger Band = 20-period simple moving average
Upper Bollinger Band = Middle Bollinger Band + 2 * 20-period standard deviation
Lower Bollinger Band = Middle Bollinger Band - 2 * 20-period standard deviation
BandWidth defines the current width of the band.
%b defines the current position within the band.
BandWidth = (Upper Bollinger Band - Lower Bollinger Band) / Middle Bollinger Band
%b = (Last - Lower Bollinger Band) / (Upper Bollinger Band - Lower Bollinger Band)
Live Samples:
Bottlenecks in bandwidth indicate an upcoming change. Break up through the moving average line or continuous movements above the moving average line indicate a break up, and vice versa.
Source: http://www.bollingerbands.com
Green day on Wednesday for Theravance Biopharma stock after gaining 2.28%
(Updated on Jul 03, 2024)
The Theravance Biopharma stock price gained 2.28% on the last trading day (Wednesday, 3rd Jul 2024), rising from $8.32 to $8.51. During the last trading day the stock fluctuated 3.97% from a day low at $8.19 to a day high of $8.51. The price has risen in 7 of the last 10 days and is up by 0.35% over the past 2 weeks. Volume has increased on the last day along with the price, which is a positive technical sign, and, in total, 71 thousand more shares were traded than the day before. In total, 231 thousand shares were bought and sold for approximately $1.97 million.
The stock lies in the middle of a wide and falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -11.19% during the next 3 months and, with a 90% probability hold a price between $6.76 and $8.20 at the end of this 3-month period. Do note, that if the stock price manages to stay at current levels or higher, our prediction target will start to change positively over the next few days as the conditions for the current predictions will be broken.
Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.
TBPH Signals & Forecast
A buy signal was issued from a pivot bottom point on Tuesday, July 02, 2024, and so far it has risen 2.28%. Further rise is indicated until a new top pivot has been found. Volume is rising along with the price. This is considered to be a good technical signal. Some negative signals were issued as well, and these may have some influence on the near short-term development. The Theravance Biopharma stock holds a buy signal from the short-term Moving Average; at the same time, however, the long-term average holds a general sell signal. Since the longterm average is above the short-term average there is a general sell signal in the stock giving a more negative forecast for the stock. On further gains, the stock will meet resistance from the long-term Moving Average at $8.72. On a fall, the stock will find some support from the short-term average at $8.42. A break-up through the long-term average will give another buy signal, while a fall below the short-term average will add another sell signal and strengthen the general signal. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD).
A buy signal from a double bottom formation was found on Tuesday, July 02, 2024 and based on theory for this formation the price should go up by 4.16% to $8.86 within 23 trading days (Monday, August 05, 2024) since signal was issued.
Support, Risk & Stop-loss for Theravance Biopharma stock
Theravance Biopharma finds support from accumulated volume at $8.48 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.
This stock is usually traded at a good volume, and with minor daily changes, the risk is considered to be low. During the last day, the stock moved $0.325 (3.97%) between high and low. For the last week, the stock has had daily average volatility of 2.81%.
Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.
Trading Expectations (TBPH) For The Upcoming Trading Day Of Friday 5th
For the upcoming trading day on Friday, 5th we expect Theravance Biopharma to open at $8.40, and during the day (based on 14 day Average True Range), to move between $8.23 and $8.79, which gives a possible trading interval of +/-$0.279 (+/-3.28%) up or down from last closing price. If Theravance Biopharma takes out the full calculated possible swing range there will be an estimated 6.56% move between the lowest and the highest trading price during the day.
Since the stock is closer to the support from accumulated volume at $8.48 (0.35%) than the resistance at $8.84 (3.88%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..
Is Theravance Biopharma stock A Buy?
Theravance Biopharma holds several negative signals and we believe that it will still perform weakly in the next couple of days or weeks. We, therefore, hold a negative evaluation of this stock.
Current score: -1.611 Sell Candidate Unchanged
Predicted Opening Price for Theravance Biopharma of Friday, July 5, 2024
| Fair opening price July 5, 2024 | Current price |
|---|---|
| $8.40 ( 1.27%) | $8.51 |
The predicted opening price is based on yesterday's movements between high, low, and closing price.
Trading levels for TBPH
Fibonacci Support & Resistance Levels
| Level | Price | |
|---|---|---|
| R3 | 8.73 | 2.55% |
| R2 | 8.60 | 1.09% |
| R1 | 8.53 | 0.186% |
| Price | 8.51 | |
| S1 | 8.28 | -2.73% |
| S2 | 8.20 | -3.63% |
| S3 | 8.08 | -5.09% |
Accumulated Volume Support & Resistance Levels
| Level | Price | |
|---|---|---|
| R3 | 9.60 | 12.81% |
| R2 | 8.98 | 5.52% |
| R1 | 8.84 | 3.88% |
| Price | 8.51 | |
| S1 | 8.48 | -0.353% |
| S2 | 8.41 | -1.18% |
| S3 | 8.40 | -1.29% |
FAQ
Click here for our free guide on how to buy Theravance Biopharma Stock.
